Yair Fisher
Direttore Tecnico/Scientifico/R&S presso Glixogen Therapeutics Ltd.
Profilo
Yair Fisher is currently the Chief Scientific Officer at GliXogen Therapeutics Ltd.
He holds a doctorate degree from Ben-Gurion University of the Negev.
Posizioni attive di Yair Fisher
| Società | Posizione | Inizio |
|---|---|---|
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Direttore Tecnico/Scientifico/R&S | 01/12/2018 |
Formazione di Yair Fisher
| Ben-Gurion University of the Negev | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
- Borsa valori
- Insiders
- Yair Fisher
